Symbol
AKBA on Nasdaq
Investment type
Equity / COMMON STOCK
Latest Disclosed Shares Owned
12,685,803 shares
Security Ownership %
5.4%
Shares, Excluding Options vs Price
Value, Excluding Options

The Vanguard Group ownership in Akebia Therapeutics, Inc. COMMON STOCK (AKBA)

30 Apr 2025 - The Vanguard Group has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,685,803 shares of Akebia Therapeutics, Inc. COMMON STOCK (AKBA). This represents 5.4% ownership of the company. This is the first filing by VANGUARD GROUP INC disclosing ownership of Akebia Therapeutics, Inc. COMMON STOCK (AKBA).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.